Aesthetic Medical International Holdings Group Ltd (AIH)

$0.33

Market is closed - opens 7 PM, 09 Sep 2024

Highlights

Market Capitalization
15.9M
Book Value
$1.02
Earnings Per Share (EPS)
-0.12
Wall Street Target Price
8.93
Profit Margin
-5.48%
Operating Margin TTM
-11.23%
Return On Assets TTM
-5.51%
Return On Equity TTM
-492.08%
Revenue TTM
682.6M
Revenue Per Share TTM
15.55
Quarterly Revenue Growth YOY
10.5%
Gross Profit TTM
355.6M
EBITDA
-6.7M
Diluted Eps TTM
-0.12
Quarterly Earnings Growth YOY
12.19
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    80%Buy
    20%Hold
    0
    0%Sell
Based on 5 Wall street analysts offering stock ratings for Aesthetic Medical International Holdings Group Ltd(by analysts ranked 0 to 5 stars)
Based on 5 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
4
4
4
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 2606.06%

Current $0.33
Target $8.93

Company Financials

FY18Y/Y Change
Revenue
110.7M
↑ 9.16%
Net Income
-37.1M
↑ 232.88%
Net Profit Margin
-33.53%
↓ 22.54%
FY19Y/Y Change
Revenue
124.4M
↑ 14.15%
Net Income
19.5M
↓ 153.4%
Net Profit Margin
15.68%
↑ 49.21%
FY20Y/Y Change
Revenue
138.2M
↑ 3.74%
Net Income
-37.9M
↓ 281.14%
Net Profit Margin
-27.39%
↓ 43.07%
FY21Y/Y Change
Revenue
101.3M
↓ 28.39%
Net Income
-105.1M
↑ 171.16%
Net Profit Margin
-103.71%
↓ 76.32%
FY22Y/Y Change
Revenue
97.2M
↑ 3.79%
Net Income
-11.0M
↓ 88.63%
Net Profit Margin
-11.36%
↑ 92.35%
FY23Y/Y Change
Revenue
682.6M
↑ 1.86%
Net Income
-37.4M
↓ 50.82%
Net Profit Margin
-5.48%
↑ 5.88%
Q3 FY22Q/Q Change
Revenue
-24.1M
↓ 196.43%
Net Income
-6.8M
↑ 4336.19%
Net Profit Margin
28.37%
↑ 28.99%
Q4 FY22Q/Q Change
Revenue
72.9M
↓ 393.24%
Net Income
-3.4M
↓ 51.31%
Net Profit Margin
-4.71%
↓ 33.08%
Q1 FY23Q/Q Change
Revenue
21.7M
↓ 70.4%
Net Income
26.5K
↓ 100.77%
Net Profit Margin
0.12%
↑ 4.83%
Q2 FY23Q/Q Change
Revenue
23.5M
↑ 14.47%
Net Income
-1.5M
↓ 5901.65%
Net Profit Margin
-6.2%
↓ 6.32%
Q3 FY23Q/Q Change
Revenue
181.6M
↑ 6.58%
Net Income
-13.7M
↑ 29.53%
Net Profit Margin
-7.53%
↓ 1.33%
Q1 FY24Q/Q Change
Revenue
181.6M
↑ 0.0%
Net Income
-13.7M
↑ 0.0%
Net Profit Margin
-7.53%
↑ 0.0%
FY18Y/Y Change
Total Assets
98.4M
↑ 17.05%
Total Liabilities
38.4M
↓ 56.01%
FY19Y/Y Change
Total Assets
149.9M
↑ 54.78%
Total Liabilities
65.4M
↑ 72.91%
FY20Y/Y Change
Total Assets
159.2M
↓ 0.86%
Total Liabilities
93.9M
↑ 34.13%
FY21Y/Y Change
Total Assets
90.5M
↓ 44.42%
Total Liabilities
119.8M
↑ 24.66%
FY22Y/Y Change
Total Assets
79.2M
↓ 5.3%
Total Liabilities
97.5M
↓ 11.94%
FY23Y/Y Change
Total Assets
560.7M
↑ 2.62%
Total Liabilities
527.0M
↓ 21.6%
Q3 FY22Q/Q Change
Total Assets
80.3M
↑ 0.46%
Total Liabilities
97.8M
↓ 7.12%
Q4 FY22Q/Q Change
Total Assets
93.8M
↑ 13.09%
Total Liabilities
87.5M
↓ 13.42%
Q1 FY23Q/Q Change
Total Assets
79.5M
↓ 15.54%
Total Liabilities
97.8M
↑ 11.45%
Q2 FY23Q/Q Change
Total Assets
83.1M
↑ 10.26%
Total Liabilities
78.7M
↓ 15.13%
Q3 FY23Q/Q Change
Total Assets
560.7M
↓ 6.93%
Total Liabilities
527.0M
↓ 7.63%
Q1 FY24Q/Q Change
Total Assets
560.7M
↑ 0.0%
Total Liabilities
527.0M
↑ 0.0%
FY18Y/Y Change
Operating Cash Flow
711.6K
↓ 93.64%
Investing Cash Flow
-11.1M
↑ 10.1%
Financing Cash Flow
9.7M
↓ 336.78%
FY19Y/Y Change
Operating Cash Flow
12.4M
↑ 1672.8%
Investing Cash Flow
-16.3M
↑ 49.87%
Financing Cash Flow
11.4M
↑ 19.21%
FY20Y/Y Change
Operating Cash Flow
-129.3K
↓ 100.97%
Investing Cash Flow
-19.5M
↑ 11.56%
Financing Cash Flow
2.7M
↓ 77.76%
FY21Y/Y Change
Operating Cash Flow
8.0M
↓ 6160.62%
Investing Cash Flow
-1.8M
↓ 90.95%
Financing Cash Flow
-7.1M
↓ 355.61%
FY22Y/Y Change
Operating Cash Flow
-10.9M
↓ 247.04%
Investing Cash Flow
451.1K
↓ 126.99%
Financing Cash Flow
6.6M
↓ 200.7%
Q3 FY19Q/Q Change
Operating Cash Flow
0.0
↓ 100.0%
Investing Cash Flow
0.0
↓ 100.0%
Financing Cash Flow
0.0
↓ 100.0%
Q4 FY19Q/Q Change
Operating Cash Flow
5.9M
-
Investing Cash Flow
0.0
-
Financing Cash Flow
10.8M
-

Technicals Summary

Sell

Neutral

Buy

Aesthetic Medical International Holdings Group Ltd is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin

Institutional Holdings

  • IDG Technology Venture Investment IV LLC

    0.83%

  • JPMorgan Chase & Co

    0.32%

  • Barclays PLC

    0.18%

  • Rhumbline Advisers

    0.04%

  • Renaissance Technologies Corp

    0.03%

Company Information

Organization
Aesthetic Medical International Holdings Group Ltd
Employees
1286
CEO
Dr. Pengwu Zhou
Industry
Health Services

Discover More

FAQs